Search Results - "Sayınalp, Nilgun"

The factors affecting early death in newly diagnosed APL patients by Ciftciler, Rafiye, Haznedaroglu, Ibrahim Celalettin, Aksu, Salih, Ozcebe, Osman, Sayınalp, Nilgun, Malkan, Umit Yavuz, Buyukasık, Yahya

“…In the past, acute promyelocytic leukemia (APL) was considered as one of the most rapidly lethal form of acute myeloid leukemia (AML). The objective of this…”
Get full text

Comparison of bortezomib-cyclophosphamide-dexamethasone versus bortezomib-dexamethasone based regimens in newly diagnosed multiple myeloma patients by Ciftciler, Rafiye, Goker, Hakan, Buyukasik, Yahya, Sayınalp, Nilgun, Haznedaroglu, Ibrahim C., Aksu, Salih, Ozcebe, Osman, Demiroglu, Haluk

“…The treatment landscape and clinical outcome of multiple myeloma (MM) patients have changed in the last decades, with an improved median survival of 8-10…”
Get full text

Indications and outcomes of splenectomy for hematological disorders by Ciftciler, Rafiye, Pasayeva, Aysel, Aksu, Salih, Ozcebe, Osman, Sayınalp, Nilgun, Malkan, Umit Yavuz, Buyukasık, Yahya, Haznedaroglu, Ibrahim C.

“…Splenectomy is a frequent component of the diagnosis and treatment of hematological disorders. The aim of this study was to define the indications and outcomes…”
Get full text

Renin angiotensin system genes are biomarkers for personalized treatment of acute myeloid leukemia with Doxorubicin as well as etoposide by Turk, Seyhan, Turk, Can, Akbar, Muhammad Waqas, Kucukkaraduman, Baris, Isbilen, Murat, Demirkol Canli, Secil, Malkan, Umit Yavuz, Okay, Mufide, Ucar, Gulberk, Sayinalp, Nilgun, Haznedaroglu, Ibrahim Celalettin, Gure, Ali Osmay

“…Despite the availability of various treatment protocols, response to therapy in patients with Acute Myeloid Leukemia (AML) remains largely unpredictable…”
Get full text

Convalescent (immune) plasma treatment in a myelodysplastic COVID-19 patient with disseminated tuberculosis by Çınar, Olgu Erkin, Sayınalp, Başak, Aladağ Karakulak, Elifcan, Avşar Karataş, Ayşe, Velet, Mustafa, İnkaya, Ahmet Çağkan, Ersoy Ortaç, Nazmiye Ebru, Öcal, Serpil, Aksu, Salih, Haznedaroğlu, İbrahim Celalettin, Sayınalp, Nilgün, Özcebe, Osman İlhami

“…During the ongoing COVID-19 pandemic due to the SARS-CoV-2 virus of which evidence-based medical paradigms cannot be easily applied; difficult clinical…”
Get full text

Evaluation of Prognostic Significance of the International Staging System According to Glomerular Filtration Rate in Newly Diagnosed Multiple Myeloma Patients Eligible for Autologous Stem Cell Transplantation by Çiftçiler, Rafiye, Göker, Hakan, Demiroğlu, Haluk, Haznedaroğlu, İbrahim Celalettin, Sayınalp, Nilgün, Aksu, Salih, Özcebe, Osman, Büyükaşık, Yahya

“…The prognosis of multiple myeloma (MM) patients is highly heterogeneous. The aim of this study is to determine the impact of patients’ renal functions on the…”
Get full text

Evaluation of the Survival Outcomes of Multiple Myeloma Patients According to their Plasmacytoma Presentation at Diagnosis by Çiftçiler, Rafiye, Göker, Hakan, Demiroğlu, Haluk, Aksu, Salih, Sayınalp, Nilgun, Haznedaroğlu, İbrahim C., Malkan, Ümit Yavuz, Büyükaşık, Yahya, Özcebe, Osman

“…Multiple myeloma (MM) associated with extramedullary (EM) plasmacytoma has a poor therapeutic response and poor outcomes when treated with conventional…”
Get full text

Management of Primary Immune Thrombocytopenia: Turkish Modified Delphi-Based Consensus Statement for Special Considerations by Ümit, Elif Gülsüm, Demir, Ahmet Muzaffer, Ar, Muhlis Cem, Ayer, Mesut, Aylı, Meltem, Karakuş, Volkan, Kaya, Emin, Özkalemkaş, Fahir, Sayınalp, Nilgün, Sönmez, Mehmet, Şahin, Fahri, Toprak, Selami Koçak, Toptaş, Tayfur, Yavaşoğlu, İrfan, Çalış, Ümran

“…Primary immune thrombocytopenia (ITP) is an acquired disorder of platelets with a complex and unclear mechanism of increased immune destruction or impaired…”
Get full text

Endocrine Disorders in Adult Beta-Thalassemia Patients: Insights from a Long-Term Follow-Up by Seda Hanife Oğuz, Müfide Okay, Ahmet Burak Fedai, Şule Ünal, Fatma Gümrük, Nilgün Sayınalp, Uğur Ünlütürk

Get full text

The Impact of Early Versus Late Platelet and Neutrophil Recovery after Induction Chemotherapy on Survival Outcomes of Patients with Acute Myeloid Leukemia by Çiftçiler, Rafiye, Haznedaroğlu, İbrahim C., Sayınalp, Nilgün, Özcebe, Osman, Aksu, Salih, Demiroğlu, Haluk, Göker, Hakan, Malkan, Ümit Yavuz, Büyükaşık, Yahya

“…The prognosis of patients with acute myeloid leukemia (AML) is affected by factors that are both patient- and disease-specific. The aim of this study is to…”
Get full text

Comparison of Myeloablative Versus Reduced-Intensity Conditioning Regimens for Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia: A Cohort Study by Çiftçiler, Rafiye, Göker, Hakan, Demiroğlu, Haluk, Aladağ, Elifcan, Aksu, Salih, Haznedaroğlu, İbrahim Celalettin, Sayınalp, Nilgün, Özcebe, Osman, Tekin, Fatma, Büyükaşık, Yahya

“…Allogeneic hematopoietic stem cell transplantation (HSCT) is an effective treatment modality for a variety of malignant and non-malignant hematologic…”
Get full text

CD34+ hematopoietic progenitor cell dose as a predictor of engraftment and survival in multiple myeloma patients undergoing autologous stem cell transplantation by Aladağ Karakulak, Elifcan, Demiroğlu, Haluk, Büyükaşik, Yahya, Turgut, Mehmet, Aksu, Salih, Sayinalp, Nilgün, Haznedaroğlu, Ibrahim Celalettin, Özcebe, Osman Ilhami, Göker, Hakan

“…High-dose melphalan and autologous hematopoietic stem cell transplantation (AHSCT) is the standard treatment strategy for multiple myeloma (MM) patients who…”
Get full text

Four-Dimensional Echocardiographic Evaluation of Left Ventricular Systolic Functions in Patients with Chronic Myeloid Leukaemia Receiving Tyrosine Kinase Inhibitors by Karakulak, Ugur Nadir, Aladag, Elifcan, Hekimsoy, Vedat, Sahiner, Mehmet Levent, Kaya, Ergun Baris, Ozer, Necla, Aksu, Salih, Demiroglu, Haluk, Goker, Hakan, Buyukasik, Yahya, Ozcebe, Osman, Sayinalp, Nilgun, Haznedaroglu, Ibrahim Celalettin

“…Tyrosine kinase inhibitors (TKIs) are established treatment for haematological malignancies. However, cardiac adverse effects, including the reduction in left…”
Get full text

Management of Adult Primary Immune Thrombocytopenia: Delphi-Based Consensus Recommendations by Demir, Ahmet Muzaffer, Ümit, Elif Gülsüm, Ar, Muhlis Cem, Ayer, Mesut, Aylı, Meltem, Karakuş, Volkan, Kaya, Emin, Özkalemkaş, Fahir, Sayınalp, Nilgün, Sönmez, Mehmet, Şahin, Fahri, Toprak, Selami Koçak, Toptaş, Tayfur, Yavaşoğlu, İrfan, Çalış, Ümran

“…Primary immune thrombocytopenia (pITP) is an acquired autoimmune disorder related to the increased destruction and/or impaired production of platelets. Its…”
Get full text

A single-center experience of haploidentical stem cell transplantation in hematological malignancies by Malkan, Ümit Yavuz, Göker, Hakan, Demiroğlu, Haluk, Tekin, Fatma, Akdemir, Nadire Buket, Karakulak, Elifcan Aladağ, Sayınalp, Nilgün, Haznedaroğlu, İbrahim Celalettin, Özcebe, Osman İlhami, Büyükaşık, Yahya

“…Since well-designed prospective comparative trials are lacking, haploidentical hematopoietic stem cell transplantations approach should be based on the…”
Get full text

Prophylactic Central Nervous System Irradiation Is Not Indispensable in Adult Patients with Acute Lymphoblastic Leukemia: A Multicenter Retrospective Cohort Study by Çınar, Olgu Erkin, Göker, Hakan, Fidan, Kemal, Aydın, Öznur, Pashayev, Tural, Malkan, Ümit Yavuz, Velet, Mustafa, Büyükaşık, Yahya, Aksu, Salih, Özcebe, Osman İlhami, Haznedaroğlu, İbrahim Celalettin, Sayınalp, Nilgun, Vural, Filiz, Turgut, Mehmet, Ünal, Ali, Demiroğlu, Haluk

“…Objective: Studies comparing the efficacy and safety of prophylactic regimens for central nervous system (CNS) involvement in acute lymphoblastic leukemia…”
Get full text

Efficacy of eltrombopag in thrombocytopenia after hematopoietic stem celltransplantation by Karataş, Ayşe, Göker, Hakan, Demiroğlu, Haluk, Malkan, Ümit Yavuz, Velet, Mustafa, Çınar, Olgu Erkin, Erdoğdu, Batuhan, Karadeniz, Mine, Sayınalp, Nilgün, Aksu, Salih, Haznedaroğlu, İbrahim Celalettin, Özcebe, Osman İlhami, Büyükaşık, Yahya

“…Thrombocytopenia is a common complication following hematopoietic stem cell transplantation (HSCT). Eltrombopag has been used in thrombocytopenia treatment…”
Get full text

The impact of JAK/STAT inhibitor ruxolitinib on the genesis of lymphoproliferative diseases by Türk, Can, Okay, Müfide, Türk, Seyhan, Temirci, Elif Sena, Javad, Osama, Aksu, Salih, Sayınalp, Nilgün, Haznedaroğlu, İbrahim Celalettin

“…Ruxolitinib, a JAK/STAT signaling pathway inhibitor targeted drug, has been approved for the controlling of disease symptoms and splenomegaly in patients with…”
Get full text

The impact of At1r inhibition via losartan on the anti-leukaemic effects of doxorubicin in acute myeloid leukaemia by Ghasemi, Mehdi, Okay, Mufide, Turk, Seyhan, Naeemaee, Ronak, Guver, Ebru, Malkan, Umit Y, Aksu, Salih, Sayinalp, Nilgun, Haznedaroglu, Ibrahim C

“…Introduction: Bone marrow renin–angiotensin system(RAS) modulates acute myeloid leukaemia(AML).The aim of this study is to clarify the relationships between…”
Get full text

Unclassifiable non-CML classical myeloproliferative diseases with microcytosis: findings indicating diagnosis of polycythemia vera masked by iron deficiency by Aladağ, Elifcan, Aksu, Salih, Demiroğlu, Haluk, Sayınalp, Nilgün, Göker, Hakan, Haznedaroğlu, İbrahim Celalettin, Özcebe, Osman İlhami, Büyükaşık, Yahya

“…Polycythemia Vera (PV) is a myeloproliferative disorder characterized by overproduction of morphologically normal red blood cells (RBCs), granulocytes, and…”
Get full text